Navigation Links
UL Announces RoHS II Services for Medical and Laboratory Equipment
Date:4/30/2013

NORTHBROOK, Ill., April 30, 2013 /PRNewswire/ -- UL (Underwriters Laboratories), a world leader in advancing safety, announced today the launch of a new program supporting medical devices and laboratory equipment manufacturers in their RoHS II Directive (2011/65/EU) compliance efforts.

Many manufacturers of medical and laboratory equipment previously excluded from the Scope of the original RoHS Directive are now finding that their devices are within Scope of the recast RoHS II Directive. Manufactures placing these devices in Europe must be in compliance with the new Directive by July 22, 2014.  Due diligence on the part of these manufacturers is required to ensure that their Declaration of Conformity and Technical File meets the applicable requirements.  UL offers these manufacturers support in their due diligence efforts, including a gap analysis of their process, compilation of documents supporting the technical file, analytical testing and more.

"In order to legally market devices in the EU, medical device and laboratory equipment manufacturers must comply with many regulations, including the new RoHS II Directive," said Anil Patel, vice president and general manager of UL health sciences. "This program gives manufacturers needed support in helping to ensure that their products are in full compliance with not only safety, but environmental regulations as well - an area which is receiving increasing focus world-wide."

Under the RoHS II Directive, end-product manufacturers will work with their suppliers to manage compliance and compile technical documentation as evidence of compliance. Because the approach required by the legislation is of a general nature, integrating RoHS assessment services with other regulatory assessments can help manufacturers streamline, and thereby improve, business processes.

"We view the RoHS II Directive as a positive move in protecting our environment, and right in line with our mission at UL to support the production and use of products which are physically and environmentally safe," said Mark Leimbeck , Program Manager for UL's Health Sciences Industry. "This initiative provides us an opportunity to actively engage the industry, support streamlined efforts to ensure regulatory compliance, and provide a safer and cleaner environment for our children and ourselves."

About UL

UL is a premier global independent safety science company with more than 118 years of history. Employing more than 10,000 professionals in over 100 countries, UL has five distinct business units – Product Safety, Environment, Life & Health, Knowledge Services, and Verification Services – to meet the expanding needs of our customers and to deliver on our public safety mission.  Additional information about UL may be found at UL.com.

Contact: Tara Kambeitz
Global Marketing Manager
UL
T: +1 360 263 6987
E: Tara.L.Kambeitz@ul.com


'/>"/>
SOURCE UL
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
2. NextBio Announces Translational Medicine Partnership with Sanofi
3. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
4. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
5. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
6. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
7. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
8. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
9. ConvaTec Announces 2012 Year-End Earnings Call
10. IRIDEX Announces First Quarter 2013 Conference Call and Release Date
11. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):